MedTrace Logo

International Research Consortium on Dengue Risk Assessment, Management, and Surveillance

NCT01550016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7411

Last updated 2016-10-11

No results posted yet for this study

Summary

Improvements in diagnosis of dengue fever and prediction of which patients will get more severe disease are urgently needed to improve the treatment of patients with dengue. This is very important in places with many people who suffer from dengue but have limited health care resources. This study will enroll patients with fever which may be caused by dengue in 6 countries with high incidence of dengue over two continents (Brazil, Cambodia, El Salvador, Indonesia, Malaysia and Vietnam). All patients will be followed by a doctor with blood tests and exams until they recover. Symptoms and laboratory tests will be followed so that the cause of fever can be determined. For patients who have dengue, the investigators will look for symptoms and tests which indicate more serious disease. This study will help to determine how to identify patients with dengue fever based on symptoms and simple laboratory tests and those who will get more serious disease. It will also help to define a more standardized management of patients with dengue fever.

Conditions

  • Dengue Fever

Interventions

OTHER

Observation

Clinical follow-up and laboratory investigations.

Sponsors & Collaborators

  • European Union

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • University of Heidelberg Medical Center

    lead OTHER

Principal Investigators

  • Thomas Jänisch · Heidelberg University Medical Center

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2016-06-30
Completion
2016-10-31

Countries

  • Bangladesh
  • Brazil
  • Cambodia
  • El Salvador
  • Indonesia
  • Malaysia
  • Venezuela
  • Vietnam

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01550016 on ClinicalTrials.gov